Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Vestibular Schwannoma: early-phase trial registry
4 of 8 indexed Vestibular Schwannoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 4 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Vestibular Schwannoma: 8 US clinical trials tracked, 4 recruiting.
Vestibular Schwannoma is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Scott R. Plotkin, MD, PhD, running 1 of these trials.
Enrollment posture brief
Registry condition vestibular-schwannoma
OPEN 4 | RECR 50% | LATE 0 | EARLY 5 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Vestibular Schwannoma lists 4 open slots (50% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Vestibular Schwannoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Vestibular Schwannoma is recruiting above its size-band peers.
4 of 8 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Vestibular Schwannoma trials is spread across many organizations.
Scott R. Plotkin, MD, PhD accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Most Vestibular Schwannoma trials plan to enrol fewer than 100 people.
Median target enrolment is 36 among the 8 trials that report a genuine target (sentinel values excluded). 7 of those (87.5%) plan for fewer than 100 participants.
-
Vestibular Schwannoma research is mostly interventional.
8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
StableEyes With Active Neurofeedback
Johns Hopkins University
NCT05622344
Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients with Vestibular Schwannomas
Medical College of Wisconsin
NCT05702749
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Akouos
NCT06517888
CI Following VS Removal or Labyrinthectomy
Ohio State University
NCT03795675
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Scott R. Plotkin, MD, PhD
NCT04374305
Study of Aspirin in Patients With Vestibular Schwannoma
Massachusetts Eye and Ear Infirmary
NCT03079999
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
Massachusetts General Hospital
NCT01199978
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
National Cancer Institute (NCI)
NCT01207687
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Vestibular Schwannoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Vestibular Schwannoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Vestibular Schwannoma page
8 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Vestibular Schwannoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Scott R. Plotkin, MD, PhD sponsors the most Vestibular Schwannoma trials on record, review their full trial history before evaluating a specific study. See Scott R. Plotkin, MD, PhD's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vestibular Schwannoma condition card totals 8 registered trials; most-linked intervention bevacizumab; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.